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MouseThe balanced proliferation and cell cycle exit of neural progenitors, by generating the appropriate amount of
postmitotic progeny at the correct time and in the proper location, is required for the establishment of the
highly ordered structure of the adult brain. Little is known about the extrinsic signals regulating these
processes, particularly in the midbrain. Fibroblast growth factor (Fgf) 15, the mouse ortholog of FGF19 and
member of an atypical Fgf subfamily, is prominently expressed in the dorsolateral midbrain of the
midgestational mouse embryo. In the absence of Fgf15, dorsal midbrain neural progenitors fail to exit the cell
cycle and to generate the proper amount of postmitotic neurons. We show here that this is due to the altered
expression of inhibitory/neurogenic and proneural/neuronal differentiation helix-loop-helix transcription
factor (TF) genes. The expression of Id1, Id3, and Hes5 was strongly increased and ectopically expanded,
whereas the expression of Ascl1 (Mash1), Neurog1 (Ngn1) and Neurog2 (Ngn2) was strongly decreased and
transcription of Neurod1 (NeuroD) was completely abolished in the dorsolateral midbrain of Fgf15−/− mice.
These abnormalities were not caused by the mis-expression of cell cycle regulatory proteins such as
cyclin-dependent kinase inhibitors or retinoblastoma proteins. Furthermore, human FGF19 promotes cell
cycle exit of murine dorsal neural progenitors in vitro. Therefore, our data suggest that Fgf15 is a crucial
signaling molecule regulating the postmitotic transition of dorsal neural progenitors and thus the initiation
and proper progression of dorsal midbrain neurogenesis in the mouse, by controlling the expression of
neurogenic and proneural TFs.at Institute of Developmental
ntre for Environmental Health
Landstr. 1, 85764 Neuherberg,
W. Wurst),
l rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
The establishment of the complex and highly ordered structure of the
adult mammalian brain also requires a precisely orchestrated interplay of
extrinsic and intrinsic signals during development, that regulate the
spatial and temporal balance between self-renewal and cell cycle exit of
neural progenitors and the generation of the appropriate numbers of
postmitotic progeny. Among the intrinsic signals are TFs of the helix–
loop–helix (HLH) family, playing a particularly prominent role in the
control of progenitor proliferation, cell cycle exit and neuronal differen-
tiation (Guillemot, 2007). These TFs are therefore classiﬁed in threegroups: Proneural TFs (Ascl1 (Mash1) and Neurogenins (Neurog, Ngn))
promote the cell cycle exit of neural progenitors and initiation of
neurogenesis, and the activation of Notch signaling in adjacent progeni-
tors. Neuronal differentiation TFs (Neurod1 (NeuroD)) are induced by the
proneural TFs in postmitotic cells and control the neuronal differentiation
program. Inhibitory or neurogenic TFs (Id and Hes) directly inhibit
proneural TFs or repress proneural gene expression, thereby maintaining
the proliferative, undifferentiated state of neural progenitors. Cell cycle
proteins, such as the cyclin-dependent kinase inhibitor (cdki) Cdkn1b
(p27Kip1) and the retinoblastoma (Rb) proteins Rb1, Rbl1 (p107) andRbl2
(p130), are another type of intrinsic factors promoting cell cycle exit and
differentiation of neural progenitors (Galderisi et al., 2003; Nguyen et al.,
2006).
In contrast to the intrinsic factors, the extrinsic signals acting upstream
of these TFs or cell cycle proteins are not yet fully established, particularly
in the murine midbrain. These are mostly secreted factors, such as bone
morphogenetic protein (BMP)/transforming growth factor β (Tgfβ)
family members promoting cell cycle exit of neural progenitors (Roussa
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maintaining the proliferative state of neural progenitors, repressing
their differentiation, or promoting neurogenesis and neuronal fate
speciﬁcation in a time- and context-dependent manner (Hirabayashi
et al., 2004; Kuwabara et al., 2009;Megason andMcMahon, 2002;Wexler
et al., 2009); and members of the ﬁbroblast growth factor (Fgf) family,
which so far have been mostly implicated in the maintenance of the
proliferative neural progenitor state (Mason, 2007).
The Fgf family comprises 22 members in mammals, classiﬁed in
seven subfamilies (Itoh andOrnitz, 2008;Mason, 2007). Fgf15/19, Fgf21
and Fgf23 constitute an atypical Fgf subfamily based on their
evolutionary relationship and on the facts that these Fgfs are
transcriptionally regulated by members of the nuclear receptor class
of ligand activated TFs, possess low-afﬁnity heparin-binding sites and
therefore act in an endocrine manner, and require Klotho/β-Klotho
transmembrane proteins for efﬁcient signaling via Fgf receptors (Itoh
and Ornitz, 2008; Jones, 2008). Mouse Fgf15, despite its low amino acid
identity (between 32% and 51%), is considered the structural and
functional ortholog of human, chick and zebraﬁsh FGF19/Fgf19 (Miyake
et al., 2005;Nishimura et al., 1999;Wright et al., 2004). Fgf15 expression
is conﬁned mostly to the developing central nervous system (CNS)
(Gimeno et al., 2003; Ishibashi and McMahon, 2002; McWhirter et al.,
1997), but its functionwasﬁrst described in non-neural tissues,where it
controls bile acid homeostasis, gall bladder ﬁlling and proper morpho-
genesis of the cardiacoutﬂow tract (Choi et al., 2006; Inagaki et al., 2005;
Vincentz et al., 2005). However, a recent report indicated that Fgf15
suppresses proliferation and promotes neural differentiation during
neocortical development, although the mechanism of this proneural
activity of Fgf15 remained unclear (Borello et al., 2008). Here we show
that extrinsic Fgf15 is a crucial signaling molecule regulating the
expression of intrinsic inhibitory/neurogenic and proneural HLH TFs in
the mouse midbrain, thereby controlling the cell cycle exit of dorsal
neural progenitors and their differentiation into neurons.
Materials and methods
Mouse strains
CD-1 mice were purchased from Charles River (Kisslegg/Germany).
Generation and genotyping of Fgf15+/−mice in amixed C57BL/6-129/Sv
background was described by Wright et al. (2004). These mice were
outcrossed with CD-1 mice for 12 generations (F12). Fgf15−/− embryos
were analyzed from F1 onwards and phenotypic differences were not
detected between F1 and F12 embryos. Collection of embryonic stages
was done from timed-pregnant females of heterozygous (Fgf15+/−)
intercrosses, noon of the day of vaginal plug detectionwas designated as
embryonic day0.5 (E0.5). Embryoswere additionally staged according to
Theiler (1989). Mutant embryos were always compared to their wild-
type (Fgf15+/+) littermates and at least 3 embryos were analyzed for
each probe, genotype and stage, if not otherwise indicated in the text.
Animal treatment was conducted under federal guidelines and was
approved by the HMGU Institutional Animal Care and Use Committee.
Radioactive in situ hybridization (ISH)
Parafﬁn sections (8 μm)were processed for radioactive ([α-35S]UTP,
Amersham/UK) ISH as described in Fischer et al. (2007). Riboprobes
used were Fgf15 (McWhirter et al., 1997), Fgf8, Shh, Pax6 and En1
(Puelles et al., 2003), Wnt1 (Fischer et al., 2007), Wnt3a (Parr et al.,
1993), Id1 (Benezra et al., 1990), Id3 (Christy et al., 1991), Hes5
(Akazawa et al., 1992),Hes3 (Hirata et al., 2001),Ascl1 (Mash1),Neurog1
(Ngn1), Neurog2 (Ngn2) and Neurod1 (NeuroD) (Cau et al., 1997;
Ma et al., 1997), Helt (Mgn) (Guimera et al., 2006a),Dll1 (Bettenhausen
et al., 1995), Dusp6 (Mkp3) (Echevarria et al., 2005), Fgfr1-3 (Blak et al.,
2005), Spry2 (Minowada et al., 1999), Etv4 (Pea3) and Etv5 (Erm) (Blak
et al., 2007). Images were taken with an Axioplan2 microscope orStemiSV6 stereomicroscope using bright- and dark-ﬁeld optics,
AxioCam MRc camera and Axiovision 4.6 software (Zeiss/Germany),
and processed with Adobe Photoshop 7.0 or CS software (Adobe Systems
Inc./USA).
Immunohistochemistry (IHC)
Antigenswere detected onparafﬁn (8 μm)or cryosections (16 μm)as
reported by Brodski et al. (2003) and Puelles et al. (2004). Primary
monoclonal antibodies usedweremouse anti- 5-bromo-2′-deoxyuridine
(BrdU) (1:10; Roche Diagnostics/Germany) and βIII-Tubulin (Tubb3,
TuJ1) (1:5000; Chemicon/USA), and rat anti-Nestin (1:3; BD Pharmin-
gen/USA). Polyclonal antisera used were rabbit anti-cleaved Caspase 3
(cCasp3) (1:200; Cell Signaling/USA), phosphorylated Histone H3 (pH3)
(1:1000; Upstate/USA), Ki-67 (1:100; Vision BioSystems/UK) and
Doublecortin (Dcx) (1:80, gift from O. Reiner, Weizmann Institute of
Science/Israel). Secondary antibodies were either ﬂuorescently labelled
(Cy3/Cy2) or coupled to biotin/streptavidin-horseradish-peroxidase
(Jackson ImmunoResearch Laboratories/USA), and detected using the
VECTOR® M.O.M.™ and Vectastain ABC System (Vector Laboratories/
USA). Fluorescent images were taken with an Axiovert 200 M inverted
microscope (Zeiss) and processed with Adobe Photoshop 7.0 or CS
software.
BrdU treatments
Intraperitoneal (i.p.) injections of pregnant dams with 31 μg BrdU
(Sigma/Germany)/g body weight were performed on E11.5 for single
(10 min) or cumulative (3× every 2 hours (hrs)) labeling. Embryos
were dissected 10 min (single labeling) or 2 hrs (cumulative labeling)
after the last injection and processed for immunodetection of BrdU.
Cell countings
Ki67+ and pH3+ cells were counted on serial coronal sections from
E11.5 embryos using the Neurolucida 6 software (MBF Bioscience/USA).
Cell numbers were averaged for each genotype and subjected to tests for
the estimationof statistical signiﬁcance asdescribed in Statistical analyses.
Cell cycle exit assay
Pregnant dams from Fgf15+/− intercrosses were injected i.p. with
BrdU (31 μg/g body weight) on E10.5 (t0). Embryos were dissected
24 hrs later (t24) at E11.5 and processed for ﬂuorescent immunodetec-
tion of BrdU and Ki-67. Stained sections were evaluated with a confocal
laser scanning microscope (LSM 510 META, Zeiss). A z-stack image
series in intervals of 1 μm was recorded from each section comprising
the entire thickness of the tissue. The index Tc of cell cycle re-entry after
24 hrs was calculated by dividing the number of Ki-67+/BrdU+ double-
labeled cells by the total number of BrdU+ cells.
Immunoblotting
The anterior neural tube (fore-/midbrain and rhombomere 1) of
E11.5 embryos from Fgf15+/− intercrosses was dissected free of
non-neural tissues and eye cups in ice-cold tissue lysis buffer (20 mM
Tris pH7.5, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100,
protease and phosphatase inhibitors (complete Mini and PhosSTOP,
Roche)) and homogenized in 100 μl tissue lysis buffer. The remaining
embryonic tissue was used for PCR genotyping. Total protein content
was determined by Bradford assay (Sigma-Aldrich/Germany). Equal
amounts of total protein from tissue lysates were separated in 4–12%
Criterion XT Bis-Tris Precast gels (Bio-Rad/Germany) together with
controls and a biotinylated protein ladder following themanufacturer's
instructions (PhosphoPlus Rb antibody kit, Cell Signaling), and blotted
onto nitrocellulose membranes (Hybond-ECL, GE Healthcare Europe/
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(Ser807/811) (1:1000; Cell Signaling) and anti-RBL1 (p107) (1:2000;
Santa Cruz Biotechnology/USA); and mouse anti-Cdkn1b (p27Kip1)
(1:2500; BD Pharmingen), anti-RB1 (p110) (1:500; BD Pharmingen)
and anti-active (dephosphorylated) β-Catenin (1:1000; Upstate) anti-
bodies. Membranes were stripped in 0.2 M Glycine-HCl pH2.5, 0.1%
Tween-20, and reprobed with mouse anti-β-Actin antibody (1:5000;
Abcam/UK) as a loading control. Densitometric analysis of the
immunoblots was performed with a GS-800 Calibrated Densitometer
(Bio-Rad) and ImageJ 1.34 s software (NIH/USA). Variations in total
protein contentwere correctedwithin each blot by using the amount of
β-Actin protein as standard.
Primary cell cultures and clonal analyses
Primary cortical progenitor cell cultures were prepared from E12.5
CD-1 embryos as described inHartfuss et al. (2001). Cellswereplated at a
density of 800,000 cells/well on poly-D-lysine coated coverslips and
infected with a green ﬂuorescent protein (GFP)-expressing retrovirus
2 hrs after platingas reportedbyMalatesta et al. (2000). Threehours after
retroviral infection and with each medium change, recombinant human
FGF19 protein (R&D Systems/USA) was added to a ﬁnal concentration
of 5 ng/ml. After 7 days in culture, cells were ﬁxed and processed for
immunocytochemical detection of GFP and Tubb3 as described in
Berninger et al. (2007). GFP+ cell clones were evaluated with an
Axioplan2microscope/AxioCamHRmcamera (Zeiss), and the number ofFig. 1. Fgf15 is expressed indorsal regionsof themousemidbrain. (a–t) Representative sagittal (
coronal level indicatedby broken lines ina, f, k, p)ofwild-type (CD-1)mouseembryos atE9.5 (a
i, s), respectively. Insets in (c, h, m, r, o) are pseudo-colored overlays of consecutive sections
overlapping expression domains appear in yellow. Fgf15 is expressed in the dorsal di-, mes-
arrowheads ing and insets inh,m, r), and sparing theRP (white arrowhead ine, j, t) and the Shh+
Di, diencephalon; DT, dorsal thalamus; FP, ﬂoor plate; Mes, mesencephalon; Met, metencephaGFP+ andGFP+/Tubb3+double-labeled cellswas counted for each clone
using Axiovision 4.6 software (Zeiss). The mean was calculated from
the total number of clones analyzed with or without FGF19 treatment±
s.e.m. Data were derived from four independent experiments.
Statistical analyses
For analysis of the effect of an experimental factor (genotype or
treatment) with data from different brain regions or several
independent experiments, two-way ANOVA was applied. First, an
ANOVA with interaction between factor and experiment was ﬁtted. If
the interaction effect was signiﬁcant, t-tests were performed for the
individual experiments. Otherwise a two-way ANOVA without
interaction effect was ﬁtted, and post-hoc t-tests with P-value
adjustment according to Holm (1979) were performed. For cell
cycle experiments with several sections per embryo, genotypes were
compared by one-way ANOVA for repeated measurements. For all
calculations, the R software with the nlme package was used
(Pinheiro et al., 2008; R Development Core Team, 2009).
Results
Fgf15 is expressed in dorsal regions of the mouse midbrain
We ﬁrst mapped the expression of Fgf15 in relation to Fgf8 and Shh,
two crucial signaling molecules controlling antero-posterior (A/P) anda–c, f–h, k–m,p–r) andcoronalmidbrain (d, e, i, j, n, o, s, t) sections (anterior left, dorsal top;
–e), E10.5 (f-j), E11.5 (k-o) andE12.5 (p–t). (b, g, l, q, e, j, t) aredarkﬁeld views of (a, f ,k, p, d,
hybridized with probes for Fgf15 (red) and Fgf8 (green in c, h, m, r) or Shh (green in o);
and metencephalon, with a gap in the rostral Fgf8+ domain at the MHB (white arrow/
BPand FP (inset ino). Abbreviations:AP, alarplate; BP, basal plate; CbA, cerebellar anlage;
lon; POA, preoptic area; RP, roof plate; SA, septal area; T, tectum; Tel, telencephalon.
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E12.5, Fgf15 expressionwas conﬁnedmostly to dorsal regions of the di-,
mes- and metencephalon and exhibited a decreasing gradient at both
sides of the isthmic constriction (Fig. 1). Metencephalic Fgf15
transcription overlapped with the caudal Fgf8+ domain, but mesence-
phalic Fgf15 expression showed a sharp, non-overlapping border with
the rostral Fgf8+domain at themid-/hindbrain boundary (MHB). As the
midbrain was one of the most prominent sites of Fgf15 expression
within the neural tube of themidgestationalmouse embryo,we focused
our analysis on this brain region. From E9.5 to E11.5, Fgf15 was
expressed throughout the neuroepithelium in the dorsal two thirds of
the mesencephalon, sparing the roof plate (RP) and abutting the Shh+
ﬂoor (FP) and basal plate (BP) (Fig. 1). Notably, Fgf15 expression reﬁned
todiscrete sites at both sides of theRPandof the BP atE12.5,with lowest
Fgf15 transcription in an intermediate zone locatedapproximately at the
level of the dorsolateral sulcus of the midbrain (Fig. 1). Thus, Fgf15
expression is conﬁned to dorsolateral regions of the midgestational
mouse midbrain and does not overlap with Fgf8 and Shh.
Embryonic lethality and CNS defects in outbred Fgf15−/− mice
The lack of a CNS phenotype in Fgf15−/− mice on a mixed C57BL/6-
129/Sv and inbred C57BL/6 genetic background (Vincentz et al., 2005;
Wright et al., 2004) (our ownobservations), despite theprominent neural
expression of Fgf15 in themidgestational mouse embryo, prompted us to
outcross the Fgf15+/−mice into a CD-1 genetic background. The genotype
and morphologically abnormal phenotype distribution of embryos
obtained from Fgf15+/− intercrosses in the ﬁrst ﬁve (F1-F5), tenth (F10)
and twelfth (F12)outcrossgenerationsare summarized inSupplementary
Table 1. In theﬁrst and second (F1–F2) outcross generation, the frequency
of Fgf15−/− embryos recovered at E13.5 or later was much lower than
expected by the Mendelian ratios and, in particular, no Fgf15−/−mutantsFig. 2.Morphological and CNS defects in outbred Fgf15−/− embryos. (a–d) Representative im
an outbred (CD-1) genetic background. More than 30% of the outbred Fgf15−/− embryos disp
retardation at this stage. (e–h) Representative sagittal (e) and coronal (f–h) Nissl-stained se
Fgf15−/− embryos, showing a massive overgrowth and infolding of dorsal neural tissues inwere found at E17.5 and E18.5. From the third (F3) outcross generation
onwards, Fgf15−/− embryos were recovered at approximatelyMendelian
ratios up to E11.5, indicating that most mutant embryos died after this
time-point during development. The outer inspection of the Fgf15−/−
embryos showed that around 10% of the E11.5 mutants, 20% of the E12.5
mutants, and more than 30% of the E13.5 mutants displayed mor-
phological abnormalities such as a poorly vascularized chorion, pale
appearance and a clear growth retardation (Suppl. Table 1 and Fig. 2).
Sagittal and coronal sections of these morphologically abnormal mutant
embryos revealed a massive overgrowth and infolding of dorsal neural
tissues (Fig. 2). Furthermore, apoptotic cell death was dramatically
increased in the Fgf15−/− embryosdisplaying an abnormalmorphology at
E12.5, whereas it did not differ from their wild-type littermates at E11.5
(Suppl. Fig. S1). All the other Fgf15−/− embryos were morphologically
indistinguishable from their wild-type littermates (Suppl. Table 1). The
blood vessels of the perineural vascular plexus had developed normally
and were ﬁlled with erythrocytes in the E11.5 Fgf15−/− embryos
(Suppl. Fig. S1), indicating that blood supply of neural tissues was intact
in the mutant embryos up to this stage. These results showed that the
Fgf15 null mutation in an outbred (CD-1) genetic background was
embryonic lethal after E11.5, and that up to one tenth of the Fgf15−/−
embryos displayed severe CNS defects already at this stage.
Dorsal neural progenitors fail to exit the cell cycle in Fgf15−/− embryos
The massive overgrowth and infolding of dorsal neural tissues in
more than one third of the outbred Fgf15−/− embryos at E13.5
suggested a more general defect of dorsal neural tube development in
the mutant embryos. Since the frequency of morphological CNS
defects increased after E11.5 in outbred Fgf15−/− embryos, and most
of these embryos appeared to die 2 days later, we focused our analyses
on morphologically normal Fgf15−/− embryos at E11.5. Theages of an E13.5 wild-type (Fgf15+/+) embryo (a, b) and its Fgf15−/− littermate (c, d) on
layed a poorly vascularized chorion membrane, pale appearance and manifest growth-
ctions (anterior left, dorsal top; coronal level indicated by broken lines in e) from E13.5
these mutant embryos.
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Fig. 4. Increased Nestin expression and reduced amount of Dcx+/Tubb3+ postmitotic neurons in the Fgf15−/− dorsolateral midbrain. (a–h) Representative close-up views of the
dorsal midbrain (pial surface top) on coronal sections from wild-type (Fgf15+/+) (a, c, e, g) and Fgf15−/− (b, d, f, h) embryos at E11.5 (a–f) and E12.5 (g, h). Nestin expression in
the Fgf15−/− dorsolateral midbrain was increased at E11.5 (a, b), and appeared distorted at E12.5 (g, h). Postmitotic Dcx+ and Tubb3+ neurons occupied only one cell layer within
the mantle zone (MZ) of the mutants, as compared to the 2–3 cell layers in wild-type embryos (white brackets in c–f). (i, j) Representative coronal midbrain sections fromwild-type
(Fgf15+/+) (i) and Fgf15−/− (j) embryos at E12.5. Nestin expression was strongly increased in the Fgf15−/− dorsolateral midbrain (j), where Fgf15 is highly expressed in the wild-
type embryo (i). Nestin was very weakly expressed in the Fgf15−/− ventral midbrain at this stage, where Fgf15 is normally not expressed (arrows in i, j).
501T. Fischer et al. / Developmental Biology 350 (2011) 496–510expression of Pax6, En1, Fgf8, Shh,Wnt1 andWnt3awas not affected in
the mutant embryos (Suppl. Figs. S2 and S3), suggesting that regional
identities were properly induced in the absence of Fgf15. We noted,
however, that all mutants exhibited a thinner dorsal neuroepithelium,
and we thus assessed neural progenitor proliferation in these
embryos. The total number of proliferating Ki-67+ cells was
signiﬁcantly increased in the Fgf15−/− embryos, which in addition
were ectopically positioned throughout the dorsal midbrain neuroe-
pithelium, although the numbers and distribution of phospho-Histone
H3+ (pH3+) and BrdU+ cells were not severely affected in the
mutants (Fig. 3). These data suggested that the number of cyclingFig. 3. Increased numbers of proliferating dorsal neural progenitors in the Fgf15−/− embryos. (A)
from E11.5 wild-type (Fgf15+/+) (a, d, g, j) and Fgf15−/− (b, c, e, f, h, i, k, l) embryos. The Fgf15−
ProliferatingKi-67+cellswere increased andectopically positioned in the Fgf15−/−dorsal neuroe
BrdU+cellswas not severely affected in themutants (d–l). Note the thinner neuroepithelium in th
embryos. (m) The number of Ki-67+ cells/sectionwas increased from 31.67±1.43 (Fgf15+/+) to
(Fgf15−/−) in the dorsal midbrain, and from 32.0±1.95 (Fgf15+/+) to 38.13±2.06 (Fgf15−/−) i
signiﬁcant in the two-wayANOVA (asterisk, P=0.035). In post-hoc t-testswith P-value adjustme
were increased from0.77±0.07 (Fgf15+/+) to 0.87±0.04 (Fgf15−/− in thedorsal forebrain, from
(Fgf15+/+) to 0.70±0.05 (Fgf15−/−) in the dorsal hindbrain (n=4/genotype; mean±s.e.m.). T
Abbreviations: MZ, mantle zone; SVZ, subventricular zone; VZ, ventricular zone.dorsal neural progenitors was signiﬁcantly increased in the Fgf15−/−
embryos.
The thinning of the mutant dorsal neuroepithelium also suggested
that despite the increased numbers of cycling progenitors, these cells
did not generate the proper numbers of postmitotic progeny. Indeed,
Doublecortin+ (Dcx) and βIII-Tubulin+ (Tubb3, TuJ1) postmitotic
neurons were remarkably reduced and occupied only 1 cell layer in
the mantle zone (MZ) of the mutant dorsal midbrain instead of the
2–3 cell layers detected in wild-type embryos (Fig. 4). By contrast,
expression of the intermediate ﬁlament Nestin, a marker for neural
stem and progenitor cells that is down-regulated as soon as these cellsRepresentative close-up views of the dorsal midbrain (pial surface top) on coronal sections
/− embryos in (c, f, i, l) displayed a stronger phenotype than the ones shown in (b, e, h, k).
pithelium(a–c), although thenumber anddistribution of phospho-HistoneH3+(pH3+)and
e Fgf15−/− embryos. (B)Quantiﬁcation of Ki-67+ and pH3+ cells inwild-type and Fgf15−/−
34.63±1.27 (Fgf15−/−) in the dorsal forebrain, from 30.89±0.63 (Fgf15+/+) to 34.36±0.9
n the dorsal hindbrain (Fgf15+/+, n=3; Fgf15−/− n=4; mean±s.e.m.). This increase was
nt, therewasno signiﬁcance for any of the brain regions separately. (n) pH3+ cells/1000 μm2
0.60±0.03 (Fgf15+/+) to 0.73±0.04 (Fgf15−/− in thedorsalmidbrain, and from0.58±0.02
his increase was not signiﬁcant (P=0.063 for the genotype effect in the two-way ANOVA).
502 T. Fischer et al. / Developmental Biology 350 (2011) 496–510become postmitotic (Lendahl et al., 1990), was strongly increased in
the dorsal midbrain of E11.5 Fgf15−/− embryos (Fig. 4). The aberrant
expression of Nestin was even more pronounced in the mutant
embryos at E12.5. Immunostaining for Nestin at this stage was
strongest and appeared severely distorted in the Fgf15−/− dorsolat-
eral midbrain, where Fgf15 is highly expressed in the midgestational
wild-type embryo, whereas it was very weak in the mutant ventral
midbrain, where Fgf15 is normally not expressed (Fig. 4). These
results suggested that Fgf15 directly controls the postmitotic
transition of dorsal neural progenitors in the midbrain.
The increased numbers and ectopic distribution of Ki-67+ prolifer-
ating cells, aswell as the corresponding reductionof Tubb3+postmitotic
neurons, strongly suggested that dorsal neural progenitors failed to exit
the cell cycle in the Fgf15−/− embryos. Therefore, we injected BrdU into
pregnant Fgf15+/− females at E10.5, 24 hrs before dissection of the
embryos at E11.5. Double-staining for BrdU and Ki-67 should reveal the
fraction of BrdU+/Ki67+ cells that had re-entered the cell cycle during
this 24 hr-period (Fig. 5). Compared to E11.5 control embryos, this
fraction was signiﬁcantly increased by 60% in the dorsal neuroepithe-Fig. 5. Dorsal neural progenitors fail to exit the cell cycle and are ectopically positioned in Fgf1
progenitors expressKi-67 (Ki-67+/BrdU− cells, greenovals). Cells in the S-phaseof thecell cycle in
fraction of the Ki-67+/BrdU+ progeny had exited the cell cycle (G0-phase) and initiated neurona
cycle.A cell cycle exit defect in themutant embryos leads toanaccumulationofKi-67+/BrdU+pro
the cell cycle and become postmitotic (Ki-67−/BrdU+, red), theymigrate out of theVZ into theM
mostly to theVZ in thewild-type (Fgf15+/+), but are ectopically positioned in the SVZ/MZof the F
on coronal sections from wild-type (Fgf15+/+) (c) and Fgf15−/− (d, e) embryos at E11.5 (t24), tr
white arrows in c, d) are increased and ectopically positioned in the mutants. Approximately 2
(percentageofKi-67+andBrdU+cells/total BrdU+cells) of cell cycle re-entry after 24 hrswas sign
24.28±0.61, n=4; mean±s.e.m.) (f), whereas the percentage of Ki-67− and BrdU+ cells/to
approximately 11% in the Fgf15−/− embryos (Fgf15+/+, 84.86±0.41, n=3; Fgf15−/−, 75.72
measurements ANOVA. Abbreviations: G0, G1, S, G2, M, phases of the cell cycle; MZ, mantle zonelium of the Fgf15−/− embryos, whereas the complementary fraction of
BrdU+/Ki-67− cells that had exited the cell cycle during the 24 hr-
periodwas signiﬁcantly decreased by approximately 11% in themutants
(Fig. 5). Moreover, BrdU+/Ki-67+ progenitors were ectopically posi-
tioned in the SVZ of allmutant embryos analyzed, and even found in the
MZ in about 20% of the Fgf15−/− embryos (Fig. 5). These data conﬁrmed
that dorsal neural progenitors failed to exit the cell cycle and were
ectopically located in the mesencephalic neuroepithelium of the
outbred Fgf15−/− embryos.
Neurogenic/inhibitory genes are upregulated and proneural genes are
downregulated in the Fgf15−/− dorsolateral midbrain
Dorsal neural progenitors might fail to exit the cell cycle in the
Fgf15−/− embryos due to the de-regulation of crucial cell cycle
proteins, such as cdki or Rb proteins (Galderisi et al., 2003); or due to
the misexpression of neurogenic and proneural genes that in turn
regulate cell cycle exit and neuronal differentiation (Bertrand et al.,
2002). No signiﬁcant variation in the levels of phosphorylated Rb15−/− embryos. (A) Scheme depicting the experimental paradigm. (a) Proliferating neural
corporateBrdUat E10.5 (t0) (Ki-67+/BrdU+cells, yellowovals).After 24 hrs (at E11.5; t24), a
l differentiation (Ki-67−/BrdU+ cells, red ovals), while the remaining progeny continued to
liferatingcellsandreductionof theKi-67−/BrdU+G0 fraction. (b)Asneuroepithelial cells exit
Z. Ki-67+/BrdU− (green) and Ki-67+/BrdU+ (yellow) proliferating progenitors are conﬁned
gf15−/− embryos. (B) Representative close-upviews of thedorsalmidbrain (pial surface top)
eated with BrdU at E10.5 (t0). Ki-67+ (green)/BrdU+ (red) double-labeled cells (in yellow;
0% of the Fgf15−/− embryos showed a stronger cell cycle exit defect (e). (C) The index Tc
iﬁcantly increasedby60% in theFgf15−/− embryos (Fgf15+/+, 15.14±0.41, n=3; Fgf15−/−,
tal BrdU+ cells that had exited the cell cycle after 24 hrs was signiﬁcantly reduced by
±0.61, n=4; mean±s.e.m.) (g); triple asterisks: Pb0.0001 in the one-way repeated-
; SVZ, subventricular zone; VZ, ventricular zone.
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observed in the Fgf15−/− anterior neural tube at E11.5 (Suppl. Fig. S4),
suggesting that the expression of these cell cycle proteins was not
affected by the lack of Fgf15. An increased activation of the Wnt/β-
Catenin pathway was previously reported in the Fgf15−/− cortex
(Borello et al., 2008), and the phenotype of the morphologically
abnormal Fgf15−/− embryos indeed resembled a mouse mutant over-
expressing a constitutively active form of β-Catenin (Chenn and
Walsh, 2002). However, the protein levels of the activated (depho-
sphorylated) form of β-Catenin were not changed between wild-type
and Fgf15−/− brains at E11.5 (Suppl. Fig. S4).
We then analyzed the expression patterns of different HLH TFs in
the Fgf15−/− embryos between E9.5 and E11.5. These TFs may be
grouped in neurogenic factors sustaining proliferation (Hes3 and
Hes5; (Kageyama et al., 2007)), inhibitors of differentiation (Id1 and
Id3; (Ruzinova and Benezra, 2003)), or proneural factors promotingFig. 6. Strongly increased and ectopic expression of Id and Hes genes in the Fgf15−/− dorsola
wild-type (Fgf15+/+) (a, b, e, f, i, j, m, n) and Fgf15−/− (c, d, g, h, k, l, o, p) embryos at E10.5 (
higher magniﬁcations of the boxed areas in (m, o). Images in (a–d) were pseudo-colored fo
(a, c) in the ventrolateral midbrain and of Id3 (b, d) in the dorsolateral midbrain of the Fgf15−
and Id3 (i–l) expression was strongly increased and ectopically expanded (white arrowhe
arrowheads in p) of the dorsolateral midbrain neuroepithelium in mutant embryos. Abbrevcell cycle exit and neuronal differentiation (Ascl1 (Mash1), Neurog1
(Ngn1), Neurog2 (Ngn2) and Neurod1 (NeuroD); (Bertrand et al.,
2002)). Remarkably, a strong increase and ectopic expansion of Hes5
and Id3 transcription in the ventrolateral and dorsolateral Fgf15−/−
midbrain was ﬁrst detected at E10.5, and at E11.5, Id1, Id3 and Hes5
were strongly up-regulated and ectopically expressed in the mutant
dorsal midbrain (Fig. 6). By contrast, the transcription of the
proneural bHLH TFs Ascl1 and Neurog1 was diminished in the
mutant dorsolateral midbrain at E9.5 and E10.5, respectively,
(Fig. 7). At E11.5, the expression of Ascl1, Neurog1 and Neurog2
was heavily reduced, and that of Neurod1, acting downstream of
Ascl1 and Neurog2 (Guillemot, 2007), was totally silenced in the
Fgf15−/− dorsolateral midbrain (Fig. 7). These ﬁndings indicated that
Fgf15 controls the cell cycle exit and differentiation of dorsal
midbrain neural progenitors by suppressing the expression of
neurogenic and inhibitory Hes5 and Id3, and/or by activating theteral midbrain. (a–p) Representative coronal midbrain hemisections (dorsal top) from
a-d) and E11.5 (e–p). (f, h, j, l) are darkﬁeld images of (e, g, i, k), respectively. (n, p) are
r better visualization of the ISH signal. A strong increase and ectopic expression of Hes5
/− embryos was already evident at E10.5 (black arrowheads in c, d). At E11.5, Id1 (e–h)
ads in h, l), whereas Hes5 (m–p) expression extended ectopically into the MZ (white
iations: MZ, mantle zone; SVZ, subventricular zone; VZ, ventricular zone.
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Neurod1 HLH TFs.
Next, we analyzed the expression of two other genes involved in
dorsal midbrain neurogenesis in the Fgf15−/− embryos. Transcription
of the bHLH TF Helt (Heslike, Megane), required for the generation of
dorsal midbrain GABAergic neurons (Guimera et al., 2006b; Nakatani
et al., 2007), was strongly decreased in the mutant dorsolateral
midbrain at E11.5 (Fig. 8). Expression of the Notch ligand Delta-like 1
(Dll1), which is activated by Ascl1 and Neurog2 and promotes
neuronal differentiation (Bertrand et al., 2002), was also down-
regulated in the Fgf15−/− dorsolateral midbrain (Fig. 8), suggesting
that dorsal midbrain neurogenesis was blocked along the proneural
pathway in the absence of Fgf15.
Fgfr3 transcription is reduced in the Fgf15−/− midbrain
The intracellular signal transduction pathway activated by Fgf15 in
the murine anterior neural tube is still unknown (Borello et al., 2008).
We therefore analyzed the expression of Fgf signaling pathway
components in the Fgf15−/− midbrain, including the Fgf receptors
(Fgfr) 1, 2 and 3, the intracellular negative regulators and at the same
time target genes of the mitogen-activated protein kinase (MAPK)
pathway Dual speciﬁcity phosphatase 6 (Dusp6,Mkp3) and Sprouty 2
(Spry2), and the Fgf/MAPK target genes of the Ets family, Etv4 (Pea3)
and Etv5 (Erm) (Mason, 2007). Expression of Dusp6 was ectopically
expanded in the mutant dorsolateral midbrain, whereas the tran-Fig. 7. Reducedor lost expressionofproneural genes in the Fgf15−/−dorsolateralmidbrain. (a–l) R
g, i, k) and Fgf15−/− (b, d, f, h, j, l) embryos at E9.5 (a, b), E10.5 (c, d) and E11.5 (e–l). Ascl1 (Mash
strongly decreased in themutant dorsolateralmidbrain at E11.5 (open arrowheads in b, d, f, h). Tr
completely abolished in the Fgf15−/− dorsolateral midbrain at E11.5 (open arrowheads in j, l). Ascription of Fgfr3 was notably reduced in the VZ/SVZ of the Fgf15−/−
midbrain including ventral domains (Fig. 8). Expression of all other
genes (Fgfr1, Fgfr2, Spry2, Etv4 and Etv5) was not altered in the
mutant midbrain (Fig. 8). These results indicated that Fgf15 is
required, directly or indirectly, for the regulation of Dusp6 and Fgfr3
transcription in the mouse midbrain.
The human ortholog FGF19 promotes cell cycle exit of mouse cortical
progenitors in vitro
Based on the previous ﬁndings, we tested if recombinant human
FGF19 protein, the ortholog of mouse Fgf15, promotes cell cycle exit
and neuronal differentiation of cultured neural progenitor cells. We
decided to use primary cortical cultures from E12.5 wild-type (CD-1)
embryos for two reasons: ﬁrst, because most cortical cells at this stage
are neural progenitors (Borello et al., 2008), whereas dorsal midbrain
neurogenesis is already peaking at E11.5–12.5 in the mouse (Edwards
et al., 1986); second, because the amount and viability of neural
progenitor cells that can be isolated from the mouse dorsal midbrain at
E10.5–11.5 is very limited (our own observations). To follow the fate of
proliferating progenitors, cultures were infected shortly after plating
with a GFP-expressing retrovirus that can only integrate in replicating
cells (Malatesta et al., 2000). Cell cultures were maintained in the
presence of recombinant human FGF19 protein for 7 days. At day 7, we
determined the number of GFP+ cells (cells that were proliferating at
the time of retroviral infection and their progeny) and the proportion ofepresentativecoronalmidbrainhemisections (dorsal top) fromwild-type(Fgf15+/+) (a, c, e,
1; a, b, e, f) andNeurog1 (Ngn1; c, d, g, h) expression was already reduced at E9.5–10.5 and
anscription ofNeurog2 (Ngn2; i, j) was strongly decreased and ofNeurod1 (NeuroD; k, l)was
bbreviations: MZ, mantle zone; SVZ, subventricular zone; VZ, ventricular zone.
Fig. 8. Aberrant expression of other proneural genes and Fgf signal transduction components in the Fgf15−/−midbrain. (a–r) Representative coronal midbrain hemisections (dorsal top) from
E11.5wild-type (Fgf15+/+) (a, c, e, g, i, k,m,o, q) and Fgf15−/− (b, d, f, h, j, l, n, p, r) embryos. (a, b, k, l)brightﬁeld images, (c–j,m–r)darkﬁeld images.Helt (Mgn; a, b) andDll1 (c, d)expressionwas
decreased (open arrowheads in b, d), whereasDusp6 (Mkp3; e, f) transcriptionwas increased (white arrowheads in f) in themutant dorsolateral midbrain. Fgfr3 (k, l) transcriptionwas notably
decreased in the entire Fgf15−/−midbrain (open arrowheads in l). Expression of Fgfr1 (g, h), Fgfr2 (i, j), Spry2 (m, n), Etv4 (Pea3; o, p) and Etv5 (Erm; q, r)was not altered in themutantmidbrain.
505T. Fischer et al. / Developmental Biology 350 (2011) 496–510these cells co-expressing Tubb3 (proliferating progenitors that had
differentiated into neurons during the culture period) in the treated
versus untreated cultures (Fig. 9). The total number of GFP+ cells was
signiﬁcantly reduced after FGF19 treatment, indicating that FGF19
promoted the cell cycle exit of proliferating cortical progenitors in
culture (Fig. 9). Moreover, the proportion of Tubb3+/GFP+ double-
labeled cells tended to be increased in the FGF19-treated cultures, but it
did not reach statistical signiﬁcance (Fig. 9). We therefore concluded
that treatment of mouse cortical progenitors with FGF19 signiﬁcantly
enhanced their cell cycle exit and tended to increase their neuronal
differentiation.
Discussion
Here we show that Fgf15 controls the expression of neurogenic
and proneural HLH TFs in the dorsolateral midbrain of the developing
mouse embryo, thereby coordinating the postmitotic transition of
dorsal neural progenitors and the initiation and progression of dorsal
midbrain neurogenesis. In the absence of Fgf15, dorsal midbrain
neural progenitors fail to exit the cell cycle and to generate the proper
amount of postmitotic neurons. This defect correlates with a failure to
suppress the expression of inhibitory Id and Hes HLH TFs and to
activate the expression of proneural bHLH genes, leading to a massive
overgrowth of dorsal neural tissues in some cases.
Fgf15 regulates the initiation and normal progression of dorsal midbrain
neurogenesis by controlling the expression of neurogenic and proneural genes
Fgf15 exhibits a prominent, dynamic and graded expression in the
midbrain of the midgestational mouse embryo (Gimeno et al., 2002,
2003; Ishibashi and McMahon, 2002). However, Fgf15 is not requiredfor the regionalization of the midbrain as supported by the normal
expression of early patterning genes such as Fgf8, Shh, En1, Pax6,Wnt1
andWnt3a in the Fgf15−/− embryos. This is apparently in contrast to a
previous study showing that Fgf15 is required to regulate rostral
patterning in themouse forebrain (Borello et al., 2008). The reason for
this discrepant role of Fgf15 in the fore- and midbrain is not known,
but is most likely due to regional differences in the response to Fgf15
signaling. Moreover, the Fgf15−/− embryos displayed rather subtle
changes in the expression of most cortical patterning genes analyzed
by Borello et al. (2008), which could also reﬂect the deﬁcits in cortical
precursor proliferation and differentiation observed in these mutants,
as indicated by the same authors (Borello et al., 2008).
The ﬁrst evidence of an aberrant phenotype in the Fgf15−/−
midbrain was detected at the beginning of the neurogenic period at
around E9.5–10.5. At this time-point, the expression of certain
proneural and inhibitory HLH TFs initiates in the dorsal and ventral
midbrain (Andersson et al., 2006; Guillemot and Joyner, 1993;
Hatakeyama and Kageyama, 2006; Kele et al., 2006). In the wild-
type embryo, Fgf15 is strongly transcribed in the dorsolateral
midbrain where a few scattered Ascl1+ and Neurog1+ cells are ﬁrst
detected at E9.5–10.5, but Fgf15 is not expressed in the mesencephalic
Id3+ dorsal and ventral midline (RP and FP/BP) and Hes5 expression
has not yet initiated (except for a few scattered Hes5+ cells) in the
midbrain at these stages (compare Fig. 1 with Figs. 6 and 7). Thus,
Fgf15 and proneural gene expression overlap in themidbrain, whereas
the transcription of Fgf15 and of inhibitory/neurogenic HLH TFs is
mutually exclusive during this early neurogenic period. At later
embryonic stages (E11.5–12.5), when Fgf15 is transcribed in discrete
regionswith highest levels between the dorsolateral and ventrolateral
sulcus of the midbrain (Fig. 1), these distinctions are less clear. At
these stages, all proneural/neuronal differentiation and inhibitory/
Fig. 9. The human ortholog FGF19 promotes cell cycle exit of mouse cortical progenitors in vitro. (A) Representative images of primary cortical cell cultures infected with a
GFP-expressing retrovirus when plated and cultured for 7 days in vitro (DIV). Cultures were untreated (− FGF19, a–c), or maintained in the presence of recombinant human FGF19
(+ FGF19, d–f). Cells were immunostained with antibodies against GFP (green; a, d) and βIII-Tubulin (Tubb3, red; b, e); merged images are shown in (c, f). (B) Quantiﬁcation of the
total number of GFP+ cells, and of Tubb3+/GFP+ double-labeled cells (white arrowheads in c, f) within each GFP+ clone. The data shown are from four independent experiments.
The total number of GFP+ cells (proliferating progenitors at the time of retroviral infection and their progeny) was signiﬁcantly reduced after FGF19 treatment (−FGF19: 70.0±8.3;
+FGF19: 49.0±5.8, mean±s.e.m.; two-way-ANOVA: no signiﬁcant interaction (F=0.347 with 3 and 8 df, P=0.79); signiﬁcant FGF19-effect in the ANOVA without interaction:
F=5.0 with 1 and 11 df, P=0.0464 (asterisk)) (g). The proportion of Tubb3+/GFP+ double-labeled cells (proliferating progenitors that had differentiated into neurons during the
culture period) tended to be increased after FGF19 treatment, but this increase did not reach statistical signiﬁcance (−FGF19: 0.183±0.027; +FGF19: 0.256±0.052, mean±s.e.m.;
two-way-ANOVA: no signiﬁcant interaction (F=0.373 with 3 and 8 df, P=0.77); FGF19-effect in the ANOVA without interaction: F=2.1 with 1 and 11 df, P=0.176) (h).
506 T. Fischer et al. / Developmental Biology 350 (2011) 496–510neurogenic genes tested are broadly expressed in the wild-type
midbrain, including the Fgf15+ domain (Figs. 6 and 7). Notably, we
found that in the absence of Fgf15, the transcription of inhibitory/
neurogenic Id3 and Hes5 genes was up-regulated and ectopically
expanded, whereas that of proneural Ascl1 and Neurog1 genes was
down-regulated in the mutant midbrain already during the early
neurogenic period. The aberrant expression of inhibitory/neurogenic
and proneural TFs persisted at later embryonic stages and still
appeared to be most affected in the Fgf15−/−dorsolateral midbrain,
where Fgf15 is highly expressed in wild-type embryos at earlier
stages. This suggests that Fgf15 regulates the timing (initiation) and
early phases of dorsal midbrain neurogenesis in a mostly autocrine orparacrine manner, by controlling the expression of inhibitory/
neurogenic and proneural TF genes in the same or nearby cells
producing Fgf15. In this context, Fgf15might act in threeways to control
the expression of these genes in the mouse midbrain (Fig. 10): 1) Fgf15
signaling might repress the transcription of inhibitory Id3 and/or
neurogenicHes5HLHTFs, and thusde-repress the expressionof proneural
bHLHTFs (Bertrand et al., 2002; Kageyamaet al., 2005); 2) Fgf15 signaling
might repress only the transcription of Id3, which is required for the
de-repression ofHes gene expression by inhibiting Hes binding to its own
promoter (Bai et al., 2007), and thus lead to the activation of proneural
bHLHTF expression; 3) Fgf15 signalingmight activate the transcription of
proneural Ascl1 and/or Neurog1 bHLH TFs, while directly or indirectly
Fig. 10. Possible mechanisms of Fgf15 action in the murine dorsal midbrain. Fgf15 might promote the cell cycle exit and neuronal differentiation of neural progenitors by:
1) Repressing the expression of inhibitory Id3 and/or neurogenic Hes5 HLH TFs, thereby de-repressing the transcription of proneural bHLH TFs; 2) Repressing the expression of Id3,
thereby inhibiting Hes5 gene expression through negative autoregulation (Hes5 represses its own promoter) and de-repressing the transcription of proneural bHLH TFs;
3) Activating the transcription of proneural Ascl1 and/or Neurog bHLH TFs, thereby directly or indirectly suppressing the Notch signaling pathway and Hes gene expression through
induction of Dll1 in the same cell; 4) Activating the transcription of neuronal differentiation Neurod1 bHLH TF directly and/or indirectly through induction of Ascl1/Neurog. See text
for details. Abbreviations: Ascl1 (Mash1), Achaete–scute complex homolog 1; Dll1, Delta-like 1; Fgf15, Fibroblast growth factor 15; Hes5, Hairy and enhancer of split 5; Id3, Inhibitor
of DNA binding 3; Neurod1 (NeuroD), Neurogenic differentiation 1; Neurog (Ngn), Neurogenin; Notch, Notch gene homolog.
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genes in the same cell (Kageyamaet al., 2005). In the liver, Fgf15 represses
the transcription of the rate-limiting enzyme for bile acid synthesis,
Cyp7a1, via an Fgfr4-mediated intracellular signaling pathway (Inagaki
et al., 2005). It is therefore conceivable that a similar repressive
mechanism might also operate in the CNS, supporting the idea of a
de-repression of Id and Hes genes in the Fgf15−/− embryos.
Strikingly, the transcription of the neuronal differentiation bHLH TF
Neurod1was completely abolished in the Fgf15−/− dorsolateralmidbrain,
in contrast to the residual expression ofAscl1,Neurog1 andNeurog2 in this
region of the mutant brain. The loss of Neurod1 transcription might be a
direct consequence of the strongly reduced Ascl1 and Neurog1 expression
in the Fgf15−/− embryos, as Neurod1 is induced by these proneural TFs
(Guillemot, 2007).Alternatively, Fgf15 signalingmightdirectly control the
transcription of this gene as well as of the upstream activators Ascl1 and
Neurog; the lack of Fgf15 signaling and strong reduction of Ascl1/Neurog
expression would consequently lead to the complete abolishment of
Neurod1 transcription in the mutant dorsolateral midbrain (Fig. 10).
Furthermore, proliferating neural progenitors were detected at ectopic
locations within the SVZ and MZ of the Fgf15−/− dorsolateral midbrain,
suggesting that someof theneural progenitors and/or precursors undergo
normal migration to their neuronal target sites in the mutants. It is
therefore possible that these cells enter the neuronal differentiation
program but are incapable of completing it due to the lack of Neurod1.
Therefore, our ﬁndings also suggest that Fgf15 regulates the proper
progression of dorsalmidbrain neurogenesis by controlling either directly
or indirectly the expression of neuronal differentiation bHLH TF genes.
Fgf15 does not appear to control the expression of cell cycle proteins
During bone development, Fgf signaling regulates chondrocyte
growth arrest and differentiation by a rapid dephosphorylation of Rb
proteins and induction of cdki expression (Aikawa et al., 2001; Dailey
et al., 2003; Laplantine et al., 2002). The Fgf15−/− phenotype indeed
resembled the phenotype of Rb null mutants in certain aspects, such
as embryonic lethality between E11.5 and E15.5, arrested neuronal
differentiation, delayed cell cycle exit and ectopic proliferation of
neural progenitors followed by massive apoptosis (Ferguson and
Slack, 2001; Galderisi et al., 2003). We therefore hypothesized that
Fgf15 might act via the activation/dephosphorylation of Rb and/orcdki proteins in the control of cell cycle exit and differentiation of
neural progenitors. However, our data do not indicate a direct
involvement of Fgf15 signaling in the regulation of cell cycle proteins
such as the cdki Cdkn1b (p27Kip1) or the Rb1/Rbl1 proteins, as the
expression or phosphorylation levels of these proteins were not
altered in the entire Fgf15−/− anterior neural tube.
Similarly, we did not detect an alteration in the levels of depho-
sphorylated (active) β-Catenin protein in the Fgf15−/− anterior neural
tube (including forebrain, midbrain and rostral hindbrain), which
contradicts previous ﬁndings by Borello et al. (2008) showing an
increased activation of the Wnt/β-Catenin pathway in the Fgf15−/−
cortex. There might be two reasons for these contradicting ﬁndings: i)
Different experimental approaches were applied to determine Wnt/β-
Catenin pathway activity in the Fgf15−/− embryos. Borello et al. (2008)
used a Wnt/β-Catenin LacZ reporter (BATgal) allele to detect increased
numbers ofβ-galactosidase+ cells in themutants,whichmight be amuch
more sensitive approach as compared to the quantiﬁcation of depho-
sphorylated (active) β-Catenin protein levels in brain tissue lysates by
Western blot analyses used in this work. ii) Different embryonic stages
were analyzed to determine Wnt/β-Catenin pathway activity in the
Fgf15−/− embryos. The enhanced activation of the Wnt/β-Catenin
pathway in the mutants might occur only after E11.5, which was the
stage analyzed in the present work, and might thus be detected only in
E12.5 and E14.5 embryos,whichwere the stages analyzed by Borello et al.
(2008). Nevertheless, our own and previous data by Borello et al. (2008)
suggest that the regulatory function of Fgf15 in the postmitotic transition
of dorsal neural progenitors is conserved between the fore- and the
midbrain. The proliferation of neural progenitors was increased and
reduced numbers of postmitotic (Tubb3+) neurons were generated in
both cortex and dorsal midbrain of the Fgf15−/− embryos (Borello et al.
(2008) and this work).
Complementary expression of Fg15 and Fgf8 at the MHB—functional
implications
Fgf15 and Fgf8 are expressed in a complementary pattern in the
dorsal fore- and midbrain (Borello et al., 2008; Gimeno and Martinez,
2007) (this work); in particular, the dorsal mesencephalic Fgf15+
region spares the Fgf8+ andHes3+ (Suppl. Fig. S5) domain at theMHB.
Fgf8 and Hes3 are required for the maintenance of the isthmic
508 T. Fischer et al. / Developmental Biology 350 (2011) 496–510organizer at the MHB, by promoting the proliferation/survival and
inhibiting the premature differentiation, respectively, of the
corresponding neural precursor cells (Chi et al., 2003; Hirata et al.,
2001). Fgf15 has an opposite function to Hes3, by promoting the
postmitotic transition and differentiation of neural precursors, and
might antagonize the transcription of this gene. Consistently, the
expression of Fgf8 at the MHB was not altered (Suppl. Fig. S2), but
Hes3 expression appeared to be broadened along the rostro-caudal
extent of the isthmic constriction in the Fgf15−/− embryos (Suppl. Fig.
S5). This suggests that the spatial restriction of Fgf8/Hes3 and Fgf15
expression at the MHB is crucial for the proper maintenance of the
isthmic organizer and consequently for the proper development of the
mid-/hindbrain region, by providing a precise balance between
proliferation and cell cycle exit/differentiation of neural progenitor
cells within this region of the brain.
The Fgf15−/− neural phenotype is only evident in an outbred genetic
background
The Fgf15−/−mice displayed a neural phenotype only when these
mice were crossed into an outbred (CD-1) genetic background (this
work and Borello et al. (2008)). A strong effect of genetic background
was also shown for Rbl1 (p107) and Rbl2 (p130) null mutant mice,
showing a phenotype only when backcrossed into the BALB/cJ but not
in the C57BL/6 genetic background (LeCouter et al., 1998a,b). This
suggests that the control of cell cycle progression and exit in neural
tissues is particularly sensitive to second-site geneticmodiﬁers having
epistatic relationships with Fgf15 or Rbl1/Rbl2, respectively.
The embryonic lethality of the outbred Fgf15−/− mutants is most
likely not a direct consequence of the CNS defects but rather due to the
pleiotropic effects of Fgf15, including the proper formation of the
cardiac outﬂow tract (Vincentz et al., 2005). Notably, the establish-
ment of and blood ﬂow in the perineural vascular plexus was not yet
affected in the Fgf15−/− embryos at the stages analyzed here,
indicating that the neural phenotype of the mutant embryos is not
directly related to vascular or cardiac defects. The massive apoptosis
of neural and non-neural tissues in around 20% of the Fgf15−/−
embryos at E12.5, and the lethality of these embryos between E13.5
and E14.5, precluded the analysis of a possible later function of Fgf15
in neuronal fate determination and glial differentiation. Tissue-
speciﬁc conditional mutagenesis of the Fgf15 gene will be required
to circumvent these problems.
The intracellular Fgf15 signal transduction pathway in the developing
mouse CNS is still unknown but might partly differ from human and
zebraﬁsh FGF19/Fgf19
The neural phenotype of the Fgf15−/−mutants, including cell cycle
irregularities and the mis-expression of neurogenic/inhibitory and
proneural genes, was mostly restricted to the sites where Fgf15 is
expressed, such as the dorsolateral midbrain and forebrain (this
report and Borello et al. (2008)), suggesting that Fgf15 acts locally in
an autocrine or paracrine manner within the neural tube. This is in
stark contrast to the known endocrine function of intestinal Fgf15 for
the control of bile acid synthesis in the liver (Inagaki et al., 2005). The
precise mode of action and the nature of the intracellular Fgf15 signal
transduction pathway in the brain, however, remain unknown. In fact,
Fgfr4 and β-Klotho, the preferential receptor and necessary co-
receptor for FGF19/Fgf15 (Inagaki et al., 2005; Kurosu et al., 2007;
Tomiyama et al., 2010; Xie et al., 1999), are not expressed in the
developing brain at the stages analyzed here (Blak et al., 2005; Borello
et al., 2008; Ito et al., 2000). We detected a notable decrease of Fgfr3
transcription in the entire Fgf15−/− midbrain, suggesting that Fgf15
signaling directly and/or indirectly controls the expression of this Fgf
receptor. A similar, selective down-regulation of Fgfr expression
occurs in the neocortex of the Fgf15−/− embryos (Borello et al., 2008).It should be noted that Fgfr3−/− mice do not display a neural
phenotype in the midbrain (Blak et al., 2007); the down-regulation of
Fgfr3 expression in the Fgf15−/− mutants is thus unlikely to be the
primary cause of the Fgf15−/− midbrain phenotype. Fgfr3 acts
redundantly with other Fgfr to maintain the proliferative neural
progenitor pool in the dorsal telencephalon and ventral midbrain
(Kang et al., 2009; Maric et al., 2007; Saarimaki-Vire et al., 2007). In
this context, loss of Fgfr function leads to the premature depletion of
neural progenitors due to their premature cell cycle exit and
differentiation, which is the opposite phenotype of the Fgf15−/−
mutants. The down-regulation of Fgfr3 expression, however, might
contribute additionally to the Fgf15−/− neurogenic phenotype. We
also detected an up-regulation of Dusp6 (Mkp3), a phosphatase that
dephosphorylates Erk1/2 and thereby negatively regulates the Fgf/
MAPK signaling pathway (Mason, 2007), in the Fgf15−/− dorsolateral
midbrain. This suggests that Fgf15 activates the MAPK signaling
pathway by repressing the expression of Dusp6 in neural tissues. The
only transient phosphorylation of Erk reported by Borello et al. (2008)
after stimulation with Fgf15 of cortical progenitors in vitro, however,
does not support this view.
Finally, treatment of mouse cortical progenitor cultures with
recombinant human FGF19 protein increased signiﬁcantly their cell
cycle exit but had no signiﬁcant effect on their neuronal differenti-
ation. This discrepancy could be due to differences in the in vitro
versus in vivo activity of FGF19/Fgf15, as our ﬁndings are consistent
with the reduced proliferation of cortical progenitor cells after Fgf15
treatment and functional equivalence of recombinant murine Fgf15
and human FGF19 proteins in vitro reported by Borello et al. (2008).
However, the failure to signiﬁcantly enhance neurogenesis from
FGF19-treated cortical progenitor cells might also be due to inherent
mechanistic differences between Fgf15 and FGF19/Fgf19 signaling in
the brain. Apart from their low homology, the developmental
expression patterns of zebraﬁsh and especially of chicken Fgf19 differ
substantially from mouse Fgf15 (Gimeno and Martinez, 2007; Miyake
et al., 2005). Moreover, zebraﬁsh Fgf19 was reported to promote the
proliferation of neural progenitors in the fore-, mid- and hindbrain of
the ﬁsh (Miyake et al., 2005), in contrast to the cell cycle exit- and
differentiation-inducing activity of murine Fgf15 in the fore- and
midbrain of the mouse (this report and Borello et al. (2008)).
Elucidation of the intracellular signaling pathway(s) and downstream
targets of Fgf15 and Fgf19 in the developing vertebrate brain should
help in clarifying these issues.
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